Avalo Therapeutics (AVTX) Treasury Shares (2014 - 2026)
Avalo Therapeutics (AVTX) posted Treasury Shares of $190203.0 for Q1 2026, up 9510050.0% on a QoQ basis from $2.0 in Q4 2025, and up 9510050.0% year-over-year from N/an in Q1 2025.
Avalo Therapeutics (AVTX) Treasury Shares (2014 - 2026) Analysis & Trends
Avalo Therapeutics' Treasury Shares history runs 11 years deep, the most recent figure standing at $190203.0 for Q1 2026.
- Quarterly Treasury Shares rose 9510050.0% year-over-year to $190203.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $190203.0 (up 9510050.0% YoY) and the FY2025 annual result came in at $387064.0, up 19353100.0% from the prior year.
- Treasury Shares was $190203.0 for Q1 2026 at Avalo Therapeutics, up from $2.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $421397.0 in Q3 2025 and bottomed at $2.0 in Q4 2024.
- A 4-year average of $68129.0 and a median of $12481.0 in 2022 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2025 — Treasury Shares tumbled 99.99% — and 2026, when it jumped 9510050.0%.
- Avalo Therapeutics' Treasury Shares stood at $11250.0 in 2022, then slumped by 99.98% to $2.0 in 2024, then changed by 0.0% to $2.0 in 2025, then soared by 9510050.0% to $190203.0 in 2026.
- Business Quant data shows AVTX's Treasury Shares at $190203.0 in Q1 2026, $2.0 in Q4 2025, and $421397.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | 190,203.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190,203.00 |
| Mar 31, 2026 | 190,203.00 |
| Dec 31, 2025 | 2.00 |
| Dec 31, 2025 | 2.00 |
| Sep 30, 2025 | 421,397.00 |
| Sep 30, 2025 | 421,397.00 |
| Jun 30, 2025 | 2.00 |
| Jun 30, 2025 | 2.00 |
| Mar 31, 2025 | 2.00 |
| Mar 31, 2025 | 2.00 |
| Dec 31, 2024 | 2.00 |
| Dec 31, 2024 | 2.00 |
| Sep 30, 2024 | 13,712.00 |
| Sep 30, 2024 | 13,712.00 |
| Jun 30, 2024 | 22,360.00 |
| Jun 30, 2024 | 22,360.00 |
| Mar 31, 2024 | 22,360.00 |
| Mar 31, 2024 | 22,360.00 |
| Mar 31, 2022 | 11,250.00 |
| Mar 31, 2022 | 11,250.00 |